Vistaril (hydroxyzine pamoate) Capsules and Oral Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2016 CONTRAINDICATIONS Hydroxyzine is contraindicated in patients with a prolonged QT interval. PRECAUTIONS ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts